基线OCT生物标志物预测神经血管与年龄相关的黄斑退化中的视觉结果:元分析
Keean Nanji1, Justin Grad2, Amin Hatamnejad2
1Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Ophthalmology
|June 26, 2025
概括
一些基线的OCT生物标志物可以预测新血管与年龄相关的黄斑变性患者的视力敏度 (VA) 变化,这些患者接受了抗VEGF治疗. 完整的视网膜外层表明更好的VA,而视网膜内液体表明更糟糕的VA结果.
科学领域:
- 眼科医生 眼科 眼科
- 医疗成像医学成像
- 生物标志物研究 生物标志物研究
背景情况:
- 神经血管与年龄相关的黄斑变性 (nAMD) 治疗依赖于抗血管内皮生长因子 (anti-VEGF) 治疗.
- 预测性生物标志物对于定制治疗和改善患者治疗结果至关重要.
- 光学一致性断层扫描 (OCT) 为生物标记物识别提供了详细的视网膜成像.
研究的目的:
- 为了评估视力敏度 (VA) 和VA变化的基线CT国外生物标志物的预测值.
- 评估证据的确定性,这些OCT生物标志物.
- 分析6个月,12个月和24个月的预测后的抗VEGF治疗.
主要方法:
- 对29份报告进行了系统审查和元分析,其中包括8863份眼睛.
- 评估80个OCT基线生物标志物.
- 应用推,评估,开发和评估 (GRADE) 准则对预后研究的分级.
- 使用5个字母对VA的最小重要差异来解释结果.
主要成果:
- 低确定性证据表明,完整的外部限制膜和圆形区域可以更好地预测12个月后的VA.
- 低确定性证据表明,内液 (IRF),内中心点IRF和内超反射物质在12个月后预测VA更差.
- 其他生物标志物显示出具有统计学意义但低于最小重要的差异效应;然而,色素上皮质脱落,地理缩和下液 (SRF) 与12个月的视力下降有关.
结论:
- 基线的OCT生物标志物,如完整的外视网膜层和IRF,对12个月的VA结果具有低确定性预测值.
- 进一步的研究需要提高生物标志物分类的标准化和对混变量的控制.
- 了解生物标志物的预后效用可以提高对nAMD的治疗决策.
更多相关视频
07:18Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
1.9K
07:44In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
3.1K
相关概念视频
Glaucoma: Overview
782
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
782
Open Angle Glaucoma: Treatment
586
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
586
